The calcineurin regulatory subunit polymorphism and the treatment efficacy of tacrolimus for idiopathic membranous nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The calcineurin regulatory subunit polymorphism and the treatment efficacy of tacrolimus for idiopathic membranous nephropathy

Published:2018-12 Issue: Volume:65 Page:422-428
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Zhu Ying,Zhang Min,Wang Fan,Lu Jianda,Chen Ruiying,Xie Qionghong,Sun Jing,Xue Jun,Hao Chuanming,Lin Shanyan

Funder

National Natural Science Foundation of China

Shandong Province

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial;Praga;Kidney Int.,2007

2. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial;Chen;Am J Med Sci,2010

3. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial;Xu;Contrib. Nephrol.,2013

4. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids;He;J. Nephrol.,2013

5. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial;Ramachandran;Nephrology (Carlton),2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy;Frontiers in Pharmacology;2022-09-21

2. Effect of Nephritis Rehabilitation Tablets combined with tacrolimus in treatment of idiopathic membranous nephropathy;World Journal of Clinical Cases;2021-12-06

3. FKBP-CaN-NFAT pathway polymorphisms selected by in silico biological function prediction are associated with tacrolimus efficacy in renal transplant patients;European Journal of Pharmaceutical Sciences;2021-05

4. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway;Journal of Cellular and Molecular Medicine;2020-08-11

5. A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58;Human Molecular Genetics;2020-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3